About TRIO

Mission Statement

Summary of H.R. 1115, the Immunosuppressive Drug Coverage Extension Act of 1999

Background

In 1986, Congress expanded Medicare Part B to include coverage of immunosuppressive drugs for beneficiaries who had transplants that were eligible for Medicare coverage. In 1993, Congress passed legislation that gradually increased the length of coverage to 36 months following a transplant. The 36 month limit became fully effective in 1998. Individuals who receive an organ transplant need to take immunosuppressive drugs for the rest of their lives.

Summary of H.R. 1115

The bill would eliminate the 36 month limit on the coverage of immunosuppressive drugs following a transplant so that Medicare would cover these drugs as long as the beneficiary needs them.

The bill would apply to drugs furnished on or after the date of enactment.

Back to Public Policy Section

© Transplant Recipients International Organization, Inc.